Topamax (Topiramate) is an anticonvulsant medication that is primarily used for the treatment of epilepsy, but has also been approved for migraine prevention and as an adjunct to phentermine for weight loss. It is also commonly used as an off-label medication to treat bipolar disorder as well as borderline personality disorder, but there is no …
As of February 2015, the FDA approved the psychostimulant Vyvanse (Lisdexamfetamine) for the treatment of binge eating disorder. In recent years, the popularity of Vyvanse has skyrocketed as an ADHD medication, as well as among those seeking to use it for ulterior purposes such as weight loss, academics, and sports performance. Many consider the medication …
Vyvanse (Lisdexamfetamine) is a psychostimulant medication that was developed by the company Shire. It is primarily prescribed for the treatment of ADHD (attention deficit hyperactivity disorder) and works well to improve cognitive function. In addition to treating ADHD, many doctors have used the drug to help individuals with excessive daytime sleepiness and binge eating disorders. …
Adderall is arguably the single most popular psychostimulant medication on the market. In addition to being a highly effective treatment option for ADHD (attention-deficit hyperactivity disorder), it is also sometimes used to treat narcolepsy, and as an antidepressant augmentation strategy. Many doctors don’t mind prescribing this drug to patients with non-addictive personalities because it has been …
Geodon (Ziprasidone) is an atypical antipsychotic that was approved by the FDA in 2001 for the treatment of schizophrenia. It has since been approved to manage both manic and mixed states of bipolar disorder. In some cases, the drug is used as an antidepressant augmentation strategy for the treatment of refractory depression, as well as …
Risperdal (Risperidone) is an atypical antipsychotic medication that has been approved since 1994 for the treatment of schizophrenia, bipolar disorder, as well as certain cases of autism. It functions as an antagonist of the neurotransmitter dopamine. By acting as an antagonist, it reduces overall dopamine activity in the brain and helps eliminate many of the …
Latuda (Lurasidone) is a relatively new atypical antipsychotic that was approved in 2013 for the treatment of schizophrenia and depressive episodes in Type 1 Bipolar disorder. Many have made the argument that since this is a “newer” antipsychotic, it’s likely to be “better” than the crop of older medications on the market. While no single …